common.study.topics.clinical

Breast and Gynecological Cancer Treatments

common.study.values.description

The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments

This is a pilot study to test whether PYC can improve climacteric symptoms for women who have experienced either surgically or medically induced menopause as part of their treatment for breast or gynecologic cancers.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Dietary Supplement - 50 mg PYC and then placebo

4 weeks on PYC, then 4 weeks on placebo

Dietary Supplement - 100 mg PYC and then placebo

4 weeks on PYC, then 4 weeks on placebo

Dietary Supplement - Placebo and then 50 mg PYC

4 weeks on placebo, then 4 weeks on PYC

Dietary Supplement - Placebo and then 100 mg PYC

4 weeks on placebo, then 4 weeks of PYC

participant.views.study.view.additional

participant.views.study.view.scientific-title

The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments

common.study.values.clinical-trial-id

NCT03704454

participant.views.study.view.id

dL9Jwe